The federal government is taking action to reduce prescription drug costs for seniors by proposing the Medicare $2 Drug List Model.
This new initiative from the Centers for Medicare & Medicaid Services (CMS) offers a bold approach. Under the model, Medicare beneficiaries would have access to a list of generic drugs for common conditions, such as high blood pressure and high cholesterol, at a low, fixed copayment of $2 per month per medication.
This model follows a federal Executive Order 14087, designed to make essential medications more affordable and accessible. With the release of a sample drug list and a Request for Information (RFI), the agency is gathering feedback on which medications to include to meet the diverse health needs of those with Medicare coverage. The preliminary list focuses on essential generic drugs, aiming to ensure beneficiaries can afford the medications they rely on for managing chronic conditions.
From the press release:
“CMS is using every lever at its disposal to ensure people with Medicare have access to lower-cost prescriptions. The Medicare $2 Drug List Model will aim to help improve access to and affordability of low-cost generic drugs for people with Medicare prescription drug coverage, and we encourage the public to provide feedback on the model,” said CMS Administrator Chiquita Brooks-LaSure.
As previously covered by MACo, following federal action, Maryland continues to lead the way in making healthcare more accessible and affordable. Maryland approved a plan to set upper payment limits for certain high-cost prescription drugs. The newly approved plan grants authority to cap the prices that state and local governments pay for expensive medications, a move expected to significantly reduce public spending on drugs.
Medication affordability is a longstanding issue for seniors and people with disabilities. With the new model, the agency hopes to simplify costs and enhance adherence to important medications, ultimately supporting better health outcomes.
